Looking to publish in Neurotherapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginNeurotherapeutics is the official journal of the American Society for Experimental Neurotherapeutics (ASENT). It publishes critical reviews on important topics relating to the treatment of neurological disorders and original research articles in translational neuroscience, including cutting-edge therapies that cross disciplinary lines and contribute to neurotherapeutics for medical practitioners and researchers.
Looking to publish in Neurotherapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Neurotherapeutics accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Invited Review Articles
Recent Publications
Correction to: REM Sleep Deprivation Impairs Learning and Memory by Decreasing Brain O-GlcNAc Cycling in Mouse
Sang-Min Kim, Seungjae Zhang, Jiwon Park, Hyun Jae Sung, Thuy-Duong Thi Tran, ChiHye Chung, Inn-Oc Han
Speaker abstracts from ASENT 2004 Annual Meeting March 11–13, 2004
Floyd E. Bloom, Richard Chappell, Mark Corrigan, Alfred L. Goldberg, J. Timothy Greenamyre, Jeffrey Martin, Dale Schenk, A. Jon Stoessl, Robert J. Temple
Cell therapy for stroke
Sean I. Savitz, Jonathan H. Dinsmore, Lawrence R. Wechsler, Daniel M. Rosenbaum, Louis R. Caplan
The design of clinical trials for cell transplantation into the central nervous system
Pierre Cesaro
Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004
Yuyan Duan, Ilya Lipkovich, Saeeduddin Ahmed, Jonna Ahl, Thomas Hardy, Diane Haldane, Robert Baker, Mauricio Tohen, Hong Liu-Seifert, Kristine Healey, Bruce J. Kinon, Saeed Ahmed, Ilya A. Lipkovich, Mauricio F. Tohen, Vicki Hoffmann, Dong Ding, Ellen Frank, Lizheng Shi, Janey Shin, Diego Novick, Paul Berg, Haya Ascher-Svanum, Josep Maria Haro, Isabelle Gasquet, Spyridon Tziveleskis, Fabio Blandini, Marie Therese Armentero, Roberto Fancellu, Giuseppe Nappi, David White, Mark Jensen, Barry Arnason, Samuel Frank, Karl Kieburtz, Robert Holloway, Renee Wilson, Carol Zimmerman, Scott Kim, Jordan J. Elm, Barbara C. Tilley, Yuko Y. Palesch, Paulo Guimaraes, Christopher Goetz, Bernard Ravina, Karl Keiburtz, Steven M. Leventer, Karen Raudibaugh, John C. Keogh, Robert F. Kucharik, Deirdre O’Hara, Naidong Ye, Kimm Galbraith, Brian Speicher, Kevin L. Keim, Alireza Atri, Matthew L. Lopresti, Seth J. Sherman, Haline E. Schendan, Michael E. Hasselmo, Chantal E. Stern, Joseph Jankovic, Christine Hunter, Kevin Dat Vuong, R. Horowski, H. Beneš, D. Woitalla, H. Przuntek, J. Tack, George Uhl, James P. Bennett, L. H. Villarete, C. P. Liu, H. L. Weiner, M. J. Tong, A. Rassoulpour, H. Q. Wu, P. Guidetti, H. E. Scharfman, G. M. McKhann, R. R. Goodman, E. H. Bertram, R. Schwarcz, Francesco Bibbiani, Aiste Kielaite, Lauren Costantini, Thomas Chase, Irene Avila, Justin D. Oh, Edward Castañeda, Christopher P. S. Smith, Thomas N. Chase, Xiaoxia Wang, Gerda Andringa, William Bara-Jimenez, Emory Encarnacio, Michael Morris, Amy Bridgeman, Catherine Bennett, Madhavi Thomas, Tetsuo Ashizawa, Thomas Weickert, Terry Goldberg, Aaron Mishara, Jose Apud, Bhaskar Kolachana, Michael Egan, Daniel Weinberger
Frequently asked questions
How long does it take to publish?
Submission to first decision: 2 days. Submission to acceptance: 91 days.
Reformat to Neurotherapeutics using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 3900 excluding taxes for all articles; corresponding authors who are members of the American Society for Experimental Neurotherapeutics (ASENT) are eligible for a 30% discount.
Reformat to Neurotherapeutics using Livewrite Premium